HIV and Ageing – Part 1

Dr Clovis Palmer

Dr Clovis Palmer from the Burnet Institute delivering the key note address – Immunology and Ageing; lessons learnt for HIV

We know that aging with HIV is not the same as aging without HIV and that the virus makes fundamental changes to the immune system.

Half of Australia’s positive people are over 50 years old – as long-term survivors their experience of living with HIV for 25, 30 even 35 years – means that the effects of the virus and the long-term effects of some medications, are compromising their health and wellbeing.

These people experience a greater risk of age-related conditions – things like cardiovascular disease, certain cancers, kidney and liver disease, osteoporosis and cognitive impairment, years before those living without HIV.

By 2020, there is estimated to be 30,000 Australians living with HIV. The latest research suggests that while combination antiretroviral therapy has meant positive people can live longer lives, the average lifespan of those 30,000 people will be five years less than those who don’t have HIV.

In August of 2016, 4000 of the world’s top immunologists came to Melbourne for the International Congress of Immunology.  At the invitation of Professor Sharon Lewin from the Doherty Institute, inside HIV went along to a special symposium revealing some of the latest science around Immunology and Ageing.

In this, Part 1, you’ll hear Professor Lewin introduce the key note address from one of Australia’s leading researchers, Dr Clovis Palmer from the Burnet Institute.

Be sure to check out Part 2 where an extraordinary panel of the World’s best, discuss HIV and Ageing.

Please share this post